- Home
- A-Z Publications
- Current Psychiatry Research and Reviews
- Fast Track Listing
Current Psychiatry Research and Reviews - Online First
Description text for Online First listing goes here...
-
-
An Evidence-Based Comprehensive Review of Laughter Therapy in Depression Management
Authors: Arzoo Pannu, Ramesh K. Goyal and Parina KumariAvailable online: 25 October 2024More LessDepression is a widespread mental health challenge, necessitating diverse therapeutic approaches. Emerging research suggests that laughter may offer a valuable adjunctive intervention for individuals grappling with depressive symptoms. This review systematically investigates the multifaceted relationship between laughter and depression, elucidating the underlying mechanisms and potential therapeutic benefits. A comprehensive literature search was conducted across multiple electronic databases, including PubMed, PsycINFO, Scopus, and Google Scholar. Keywords used in the search included “laughter therapy,” “humor,” “depression,” “mental health,” and “psychological well-being.” The search was limited to articles published in English and included both peer-reviewed journal articles and relevant gray literature. Relevant data were extracted from each study, including the study design, sample size, participant characteristics, type of laughter intervention, duration and frequency of the intervention, outcome measures, and key findings. The extracted data were organized into tables to facilitate comparison across studies. By synthesizing findings from clinical studies, neuroscience research, and anecdotal evidence, this review examines the physiological, psychological, and social dimensions of laughter's impact on depression. Special attention is given to neurochemical pathways, stress modulation, cognitive restructuring, and social dynamics. The physiological effects of laughter on depression encompass neurochemical regulation (endorphins, serotonin, dopamine), stress reduction, and immune system modulation. Psychologically, laughter contributes to cognitive reframing, enhanced coping mechanisms, and mood regulation. Socially, it strengthens social bonds, mitigates social isolation, and fosters a positive social environment. In conclusion, this review synthesizes current knowledge on the healing potential of laughter in mitigating depression, providing a holistic understanding of its multifaceted impact. The findings underscore the importance of integrating laughter-based interventions into mental health care practices and highlight avenues for future research and clinical applications in the realm of depression treatment.
-
-
-
Correlation between Cognitive Impairment and Peripheral Biomarkers - Significance of Phosphorylated Tau and Amyloid-β in Alzheimer’s Disease: A New Insight
Available online: 16 October 2024More LessThe correlation between elevated levels of amyloid-β and phosphorylated tau (p-tau) protein and AD is widely recognized. A rise in pTau and amyloid-β levels aids in separating AD from other neurodegenerative conditions. In this study, we have assessed the correlation between cognitive impairment and peripheral biomarkers, tau and amyloid-β levels, in AD patients with mild Alzheimer's disease in order to develop protein-based markers in a more useful way. An enzyme-linked immunosorbent assay has been used to determine the levels of tau and p-tau in the serum of the different groups and it has revealed their levels to be noticeably greater in AD compared to mild AD and even higher compared to elderly controls. Based on the cutoff levels for tau, p-tau, and amyloid-β in patients with AD and mild AD, having high sensitivity and specificity, which have been described in numerous studies by respective International Research Groups (with the greatest number of pieces of available evidence), the plasma concentration of these proteins can be used as a diagnostic indicator for AD and mild AD. These levels may also offer a practical guide to their implementation in the clinical routine.
-
-
-
Investigating Challenges of Individuals with Autism Spectrum Disorder During and Post COVID-19, and Practical Suggestions for Parents and Caregivers on How to Tackle Challenges: A Systematic Review Article
Available online: 02 October 2024More LessIntroductionThe first and second waves of COVID-19 were unprecedented situations that caused turmoil in everyone’s life, especially for individuals with autism spectrum disorder (ASD) who were severely affected by the transition.
ObjectiveThis article investigates the major impacts of COVID-19 transitioning on individuals in the spectrum followed by recommendations for autistic families on addressing concerns caused by post-COVID adaptations. We have based our study on the most recent investigations of challenges and solutions provided for these individuals in COVID and post-COVID-19 transitions. We will also explain telehealth as the most practical available solution and describe its possible advantages and disadvantages. The articles have been selected from PubMed, Google Scholar, etc. according to the goals stated above.
ResultsAccording to our study, psychological problems, economic problems, reduced physical activity, sleep disorders, malnutrition, non-cooperation of children with ASD, and speech therapy were the most important challenges for people with ASD as well as their families and caregivers during the COVID-19 pandemic.
ConclusionIt was concluded the use of telehealth could be a suitable platform for many educational methods such as applied behavior analysis, visual programs, speech therapy, family positive reinforcement systems, etc. to overcome these challenges. However, this method also has certain limitations, and therefore a combination of face-to-face and telehealth methods is recommended to help patients.
-